Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T21:51:55.223Z.
Calculation as of: 2026-10-06T21:51:55.223Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 87a3ef4e55b06d985fb23947e4d9ae6563d80488a3a61227015f8099389db825
PEG RATIO
N/A
HCW Biologics Inc.
Market Cap
$545796.00
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| HCW Biologics Inc. (HCWB) | $545796.00 | N/A |
| VivoSim Labs, Inc. (VIVS)vs › | $518606.00 | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | N/A |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $667469.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | N/A |
| CDT Equity Inc. (CDT)vs › | $716854.00 | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $824550.00 | N/A |
| Ridgetech, Inc. (RDGT)vs › | $835994.00 | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $838843.00 | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
